Natalizumab for Multiple Sclerosis
Links shared publicly online about this topic
Arch Dermatol -- Abstract: Evolution of Nevi During Treatment With Natalizumab: A Prospective Follow-up of Patients Treated With Natalizumab for Multiple Sclerosis, September 20, 2010, Castela et al. 0 (2010): archdermatol.2010.243v1
archderm.ama-assn.org — “Archives of Dermatology is a monthly professional medical journal published by the American Medical Association. Archives of Dermatology publishes original, peer-reviewed reports and discussions that address the effectiveness of diagnosis and treatment in medical and surgical dermatology, pediatric and geriatric dermatology, and oncologic and aesthetic dermatologic surgery” View full resource at archderm.ama-assn.org
Most Recently Shared on September 21, 2010 at 11:43 am By:
Evolution of Nevi During Treatment With Natalizumab: A Prospective Follow-up of Patients Treated With Natalizumab ... http://bit.ly/9FfhOG
Natalizumab Reduces Relapses And Disability In Multiple Sclerosis
medicalnewstoday.com — “Taking the new generation anti-inflammatory drug natalizumab for two years lowers the number of remitting multiple sclerosis patients who experience relapses and progression of disability. This is” View full resource at medicalnewstoday.com
Most Recently Shared on October 6, 2011 at 7:05 am By:
Natalizumab Reduces Relapses And Disability In Multiple Sclerosis http://mnt.to/4262 #multiplesclerosis
Tysabri (natalizumab), PML (progressive multifocal leukoencephalopathy), and Ongoing Research - Multiple Sclerosis
healthcentral.com — “Of the available disease-modifying treatments for multiple sclerosis, Tysabri (natalizumab) has arguably been the most controversial to date. The reason f...” View full resource at healthcentral.com
Most Recently Shared on December 17, 2010 at 2:27 am By:
Tysabri (natalizumab), PML (progressive multifocal leukoencephalopathy), and Ongoing Research http://ow.ly/1ausyL
Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis
neurology.org — “Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis” View full resource at neurology.org
Most Recently Shared on May 31, 2011 at 1:50 pm By:
Neurology Journal Medical Journal and Neurology
Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis http://bit.ly/lr1HsA #neurology
Multiple Sclerosis Research: Natalizumab PML Update - Aug 2011
multiple-sclerosis-research.blogspot.com — “Multiple Sclerosis Research: Natalizumab PML Update - Aug 2011” View full resource at multiple-sclerosis-research.blogspot.com
Most Recently Shared on October 22, 2011 at 8:28 pm By:
@jcberrypdx Nice graphs re: PML risk and JCV status as of Aug update with 159 Tysabri-PML cases http://t.co/erz6XWCj
Medical News: FDA Updates PML Risk Info for Natalizumab - in Neurology, Multiple Sclerosis from MedPage Today
medpagetoday.com — “As expected, the FDA has approved new label language for the multiple sclerosis drug natalizumab (Tysabri) with additional detail on the risks of progressive multifocal leukoencephalopathy (PML).” View full resource at medpagetoday.com
Most Recently Shared on April 22, 2011 at 8:31 pm By:
Thomas Loarie, Jr Health Advocate
@medpagetoday FDA Updates PML Risk Info for Natalizumab http://bit.ly/i6ZA0J #medical #Health
Medical News: JC Virus Activation Called Common with Natalizumab - in Neurology, Multiple Sclerosis from MedPage Today
medpagetoday.com — “The virus responsible for progressive multifocal leukoencephalopathy (PML) showed up in blood and urine in a majority of a small series of multiple sclerosis patients taking natalizumab (Tysabri) for” View full resource at medpagetoday.com
Most Recently Shared on September 10, 2009 at 12:36 am By:
JC Virus Activation Called Common with Natalizumab (CME/CE) http://ow.ly/15OptQ
Neurology Article | Multiple Sclerosis
mdlinx.com — “Dramatic worsening following plasma exchange in severe post-natalizumab withdrawal multiple sclerosis relapse” View full resource at mdlinx.com
Most Recently Shared on June 18, 2011 at 3:04 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Dramatic worsening following plasma exchange in severe post-natalizumab withdrawal multiple sclerosis rel... http://bit.ly/mNK9eS #neuro
Safety and efficacy of natalizumab in children with multiple sclerosis -- Ghezzi et al. 75 (10): 912 -- Neurology
neurology.org — “Safety and efficacy of natalizumab in children with multiple sclerosis -- Ghezzi et al. 75 (10): 912 -- Neurology” View full resource at neurology.org
Most Recently Shared on September 7, 2010 at 11:56 am By:
Safety and efficacy of natalizumab in children with multiple sclerosis: Conclusions: Natalizumab was well-tolerate... http://bit.ly/9FJ2Rw
The efficacy of natalizumab in patients with multiple sclerosis according to level of disability: results of an observational study --" Mult Scler
msj.sagepub.com — “The efficacy of natalizumab in patients with multiple sclerosis according to level of disability: results of an observational study --" Mult Scler” View full resource at msj.sagepub.com
Most Recently Shared on February 5, 2011 at 3:01 am By:
The efficacy of natalizumab in patients with multiple sclerosis according to level of disability: results of an ... http://bit.ly/fknnSQ
NHS Evidence - Neurological conditions - A meta-analysis on the efficacy and tolerability of natalizumab in relapsing multiple sclerosis
library.nhs.uk — “Bibliographic detailsNikfar S, Rahimi R, Rezaie A, Abdollahi M. A meta-analysis on the efficacy and tolerability of natalizumab in relapsing multiple sclerosis. Archives of Medical Science 2010; 6(2): 236-244 StatusThis record is a structured abstract produced by CRD. The original has met a set of quality criteria. Since September 1996 abstracts have been sent to authors for comment. Additional factual information is incorporated into the record. Noted as [A:....]. CRD summaryThe review conclude” View full resource at library.nhs.uk
Most Recently Shared on February 5, 2011 at 3:01 am By:
A meta-analysis on the efficacy and tolerability of natalizumab in relapsing multiple sclerosis: The review conc... http://bit.ly/elVaKM
PolygenicBlog: JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab.
polygenicpathways.blogspot.com — “Concerning the relationships between genes, risk factors and immunity in Alzheimer's disease, Autism, Bipolar disorder , multiple sclerosis, Parkinson's disease, schizophrenia and chronic fatigue” View full resource at polygenicpathways.blogspot.com
Most Recently Shared on September 25, 2010 at 11:17 am By:
http://www.linkedin.com/pub/chris-carter/22/560/76a" /> Dr Chris Carter Pharmacist, PhD, Doctor, and Medical Technology
JC virus persistence following progressive multifocal leukoencephalopathy in multiple… http://goo.gl/fb/Ko6Nx
Multiple Sclerosis on #MDlinx
mdlinx.com — “Multiple Sclerosis on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 8, 2010 at 4:47 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Natalizumab in pediatric multiple sclerosis patients: Therapeutic Advances in Neurological Disorders http://bit.ly/9TOYiu #neuro
Information on Natalizumab (marketed as Tysabri)
fda.gov — “Information on Natalizumab (marketed as Tysabri)” View full resource at fda.gov
Most Recently Shared on September 16, 2009 at 7:36 pm By:
Gannett Healthcare Health News
FDA receives reports of PML in patients receiving Tysabri: http://bit.ly/SD3Nr
Natalizumab drug holiday in multiple sclerosis: Po... [Ann Neurol. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on July 29, 2010 at 5:59 am By:
George Jelinek Doctor, Emergency Physician, and Physician
Going off Tysabri can cause flare up of MS: important to be aware of this possibility http://www.ncbi.nlm.nih.gov/pubmed/20661928
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
OrganizedWisdom MS
Organizing multiple sclerosis resources shared by health experts, advocates, and organizations into WisdomCards.
-
MNT Multiple Scl
The latest multiple sclerosis news published daily. Articles from research centers, universities and prestigious journals.
-
Lisa Emrich
Patient Advocate and Blogger, Living with Multiple Sclerosis and Rheumatoid Arthritis, Musician, Educator, and writer for HealthCentral.com
Advertisement
